Jeffrey Luber

Feb 04, 2016

BG Medicine has appointed Jeffrey Luber to its board of directors. Luber replaces Noubar Afeyan, who resigned from the position. Since July 2014, Luber served as vice president of corporate development and general counsel for Good Start Genetics. Prior to that, he served as CEO of Exact Sciences, where he also served the company's president, CFO and treasurer, and general counsel.

Breaking News

Germline Genetic Testing Rates in Cancer Patients Low in California, Georgia, Study Finds
BabySeq Project Unearths Actionable Genetic Variants Impacting Infants, Parents
Illumina Appeals FTC's Order to Divest Grail, Cites Government Overreach
AccuStem, University Hospitals Partner to Establish Clinical Utility of Cancer Recurrence Test
Interpace Biosciences to Stop Offering Pancreatic Cancer Test After Losing CMS Reimbursement

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.